Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives

This article reports on the lived experience of Medtronic advanced hybrid closed-loop (AHCL) in comparison to first generation hybrid closed-loop (HCL) in a randomized, open-label, two-period crossover trial. Patient-reported outcome (PROs) measures were administered before randomization and at the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes technology & therapeutics 2021-12, Vol.23 (12), p.857-861
Hauptverfasser:	Hood, Korey K, Laffel, Lori M, Danne, Thomas, Nimri, Revital, Weinzimer, Stuart A, Sibayan, Judy, Bailey, Ryan J, Schatz, Desmond, Bratina, Natasa, Bello, Rachel, Punel, Alina, Calhoun, Peter, Beck, Roy W, Bergenstal, Richard M, Phillip, Moshe
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Blood Glucose Blood Glucose Self-Monitoring Brief Report Clinical outcomes Closed loop systems Diabetes Diabetes Mellitus, Type 1 - drug therapy Drug delivery systems Glucose monitoring Humans Hypoglycemic Agents - therapeutic use Insulin Insulin - therapeutic use Insulin Infusion Systems Medical technology Patient Reported Outcome Measures Teenagers Young Adult Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This article reports on the lived experience of Medtronic advanced hybrid closed-loop (AHCL) in comparison to first generation hybrid closed-loop (HCL) in a randomized, open-label, two-period crossover trial. Patient-reported outcome (PROs) measures were administered before randomization and at the end of each study period in 113 adolescents and young adults with type 1 diabetes. Glucose monitoring satisfaction subscales for emotional burden and behavioral burden improved significantly (
ISSN:	1520-9156 1557-8593
DOI:	10.1089/dia.2021.0153